Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
-
Rapid7 to Attend Raymond James 47th Annual Institutional Investors Conference
-
Interparfums, Inc. Reports Record 2025 Fourth Quarter and Full Year Results
-
Vir Biotechnology Announces Proposed Public Offering of Common Stock
-
Navitas Semiconductor Announces Fourth Quarter and Full Year 2025 Financial Results
-
Euroholdings Ltd Reports Results for the Quarter and Twelve-Month Period Ended December 31, 2025
-
Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
ABM to Announce First Quarter 2026 Financial Results
-
Rapport Therapeutics to Participate in Upcoming Investor Conferences
-
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
-
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
-
UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference
-
Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share
-
Aktis Oncology to Present at Upcoming March Investor Conferences
-
Datadog to Present at Upcoming Investor Conference
-
Appian Corporation to Present at the Morgan Stanley Technology, Media & Telecom Conference
-
Nature’s Sunshine Sets Fourth Quarter 2025 Conference Call for Tuesday, March 10, 2026, at 5:00 p.m. ET
-
Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends
-
Spyre Therapeutics to Participate in Upcoming March Investor Conferences
-
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
-
Revolve Group Announces Fourth Quarter and Full Year 2025 Financial Results
-
First Solar, Oxford PV Enter into Patent Licensing Agreement for US Markets
-
CoStar Group Full Year 2025: Revenue Increased 19% Year-over-Year; Net Income of $7 million; Adjusted EBITDA of $442 million, up 83% Year-over-Year; Record Net New Bookings of $308 million; $700 milli
-
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
-
MercadoLibre, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
-
478 Ameriprise Financial Advisor Teams Named to the Forbes “Best-in-State Wealth Management Teams” List
-
Flywire Reports Fourth Quarter and Fiscal-Year 2025 Financial Results
-
Insight to Present at Raymond James 47th Annual Institutional Investors Conference
-
AccuLynx Expands Roof Measurement Options with New RoofScope Integration
-
Axon reports Q4 2025 revenue of $797 million, up 39% year over year
-
Tempus Reports Fourth Quarter and Full Year 2025 Results
-
New 180-Day Devotional Invites Reader into Quiet Moments with Jesus
-
AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
-
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
-
Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
-
Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
-
Gulfport Energy Reports Fourth Quarter and Full Year 2025 Financial and Operating Results and Provides 2026 Operational and Financial Guidance
-
Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
-
NetApp to Participate in Upcoming Conferences
-
Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
-
Backblaze Appoints Rhett Dillingham Senior Vice President of Product
-
SLR Investment Corp. Announces Quarter and Year Ended December 31, 2025 Financial Results
-
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
-
Micron Technology to Report Fiscal Second Quarter Results on March 18, 2026
-
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
-
EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance
-
Todyl Launches Janus, Agentic AI for Incident Investigation
-
Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update
-
Accelerant Announces Leadership Updates Across Legal and Investor Relations
-
Intuit Chairman and CEO Sasan Goodarzi to Present at the Morgan Stanley Technology, Media and Telecom Conference
